Results 231 to 240 of about 725,440 (353)

Tumor Necrosis Factor Receptor 2 Inhibits HIV-1 Infection by Blocking the Binding of gp120 to CD4. [PDF]

Int J Biol Sci
Gao Y, Chen Z, Chen Y, Yang Y, Wang Y, Zhu C, Liao P, Song H, Chen X.   +8 more
europepmc   +1 more source

p53 and Tumor Necrosis Factor α Regulate the Expression of a Mitochondrial Chloride Channel Protein [PDF]

, 1999
Ester Fernández‐Salas, Manish Sagar, Christina Cheng, Stuart H. Yuspa, Wendy C. Weinberg   +4 more
openalex   +1 more source

Bifidobacterium Pseudolongum‐Derived Inosine Mitigates Polystyrene Nanoplastics‐Induced Hepatic Injury by Inhibiting the Polarization of M1 Macrophages

Advanced Science, EarlyView.
Probiotic B.p colonization elevated gut‐derived inosine level in the liver, while elevated inosine activated A2AR and subsequently blocked NPs‐induced polarization of M1 macrophages by repressing the miR155/SOCS1/NF‐κB pathway. This reduced the release of inflammatory cytokines and thereby, mitigated NPs‐induced hepatic injury.
Kaikai Zhang, Yuchuan Chen, Jiayuan Wan, Jianzheng Yang, Lijian Chen, Qingyuan Li, Anding Zhou, Nian Zhou, Jiuyang Ding, Qi Wang, Jian Sun   +10 more
wiley   +1 more source

Serum tumor necrosis factor-α levels in migraine: a registry for migraine (REFORM) study. [PDF]

Pain Rep
Tesfay B, Karlsson WK, Ashina H, Christensen RH, Al-Khazali HM, Olsen DA, Madsen JS, Ashina M.   +7 more
europepmc   +1 more source

Tumor Necrosis Factor [PDF]

General Internal Medicine and Clinical Innovations, 2018
openaire   +1 more source

Activation Signal of Nuclear Factor-κB in Response to Endoplasmic Reticulum Stress is Transduced via IRE1 and Tumor Necrosis Factor Receptor-Associated Factor 2

, 2003
Masayuki Kaneko, Yoshifumi Niinuma, Yasuyuki Nomura   +2 more
openalex   +1 more source

The Development and Pilot Clinical Study of CD147 Targeted Antagonistic Peptide Probe for Tumor Imaging

Advanced Science, EarlyView.
This study establishes [68Ga]Ga‐DOTA‐AP9 as a first‐in‐human CD147‐targeted PET tracer with favorable safety and specific tumor uptake. Tracer accumulation correlates with CD147 expression in patients, enabling noninvasive quantification of CD147‐positive malignancies.
Xiaokun Ma, Rui Guo, Dongfeng Niu, Yufei Song, Zhenyao Zhang, Xiangxi Meng, Lili Mao, Haifeng Huang, Hua Zhu, Zhi Yang, Teli Liu   +10 more
wiley   +1 more source

Tumor necrosis factor-alpha-mediated inflammatory bone loss: Pathogenic mechanisms and therapeutic potential of its inhibitors. [PDF]

Tzu Chi Med J
Lin WY, Pan YJ, Yeh KT, Su KY, Dharini KK, Chen IH, Wu WT, Lin MD, Peng CH.   +8 more
europepmc   +1 more source

Engineering Approaches to Modify Immunomodulatory Functions of Mesenchymal Stromal Cells (MSCs): Tissue Regeneration and Clinical Application

Advanced Science, EarlyView.
Mesenchymal stromal cells (MSCs) show promise for treating immune‐related disorders through immunomodulation and tissue regeneration. This review gives a brief overview of current clinical approval of MSC therapies. It also discussed how bioengineering, including genetic modification, biomaterial delivery, extracellular vesicles, and iPSC‐derived MSCs,
Sichen Yang, Kejia Li, Ning Wang, Zhen Li, Zhiyong Zhang, Rocky S. Tuan, Yangzi Jiang   +6 more
wiley   +1 more source

Thyroid hormone changes after tumor necrosis factor inhibitor therapy in euthyroid patients with rheumatic diseases. [PDF]

BMC Pharmacol Toxicol
Kizilkaya B, Mercantepe F, Vekic J, Cure O, Klisic A.   +4 more
europepmc   +1 more source